Grants and Contracts Details
Description
The hypothesis of this study is that the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) will suppress tumor growth, both alone and in combination with paclitaxel and cisplatin, in ovarian cancer animal models.
| Status | Finished |
|---|---|
| Effective start/end date | 6/1/04 → 6/30/05 |
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.